Solstar Pharma is a pre-clinical stage pharmaceutical company focused on bringing novel nucleic acid therapies to the market.
Our proprietary RNA interference (RNAi) chemistry platform allows for the precise optimization of small interfering RNA (siRNA) molecules designed to potentially deliver greater efficacy, safety, and tolerability when compared to other RNAi medicines.
Company Details
- Employees
- 4
- Founded
- -
- Address
- 43 Boulevard Samson, Suite 237,canada
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- solstarpharma.com
- Keywords
- Antimicrobial Resistance, Pharmaceutical, Infectious Diseases, Research & Development, siRNA, RNAi, nucleic acid medicine, cancer, oncology.
- HQ
- Laval, Quebec
Solstar Pharma Questions
Solstar Pharma's website is solstarpharma.com
Solstar Pharma's LinkedIn profile is https://ca.linkedin.com/company/solstarpharma
Solstar Pharma has
4 employees.
View email and phone details for 4
employees at Solstar Pharma.
Solstar Pharma's industry is
Pharmaceutical Manufacturing
Solstar Pharma's top competitors are
Biotech City,
Inversago Pharma,
Morphocell Technologies,
Nexelis, A Q² Solutions Company,
Rna Technologies And Therapeutics,
Prometic Bioproduction Inc.,
Inixium,
Q² Solutions,
Whitehaven,
Linear Therapies.
Solstar Pharma's categories are Pharmaceutical Manufacturing
Solstar Pharma's founding year is 2017
